Ryan D. Maynard - 06 Jun 2023 Form 4 Insider Report for IOVANCE BIOTHERAPEUTICS, INC. (IOVA)

Role: Director
Issuer symbol: IOVA
Transaction date: 06 Jun 2023
Net transaction value: $0
Form type: 4
Filing time: 08 Jun 2023, 18:21:39 UTC
Previous filing: 03 Mar 2023
Next filing: 05 Feb 2024
SEC filing: View on sec.gov
Signature: /s/ Ryan Maynard

Key filing fact

Ryan D. Maynard filed Form 4 for IOVANCE BIOTHERAPEUTICS, INC. (IOVA) on 08 Jun 2023.

Key facts

This page summarizes Ryan D. Maynard's Form 4 filing for IOVANCE BIOTHERAPEUTICS, INC. (IOVA).
1 reported transaction and 1 derivative row are listed below.
Filing timestamp: 08 Jun 2023, 18:21.

Change

Previous filing in this sequence was filed on 03 Mar 2023.
Current net transaction value: $0.

Research use

This tells you what this filing adds before you inspect full transaction and derivative tables.
You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

See Original Filing

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

IOVA transaction Derivative

Deferred Restricted Stock Unit

Award

Transaction value: $0
Shares: +51,955
Change %
Price: $0.000000
Shares after: 51,955
Date: 06 Jun 2023
Ownership: Direct
Underlying class: Common Stock
Underlying amount: 51,955
Exercise price
Footnotes: F1, F2

^* indicates a reported price that failed the local validity check.

Explanation of Responses:

Id	Content
F1	Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).
F2	Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.

Content

Each deferred restricted stock unit ("DRSU") represents a contingent right to receive one share of the Issuer's common stock and are granted pursuant to the Issuer's 2018 Equity Incentive Plan (as amended).

Provided the Reporting Person continues to be providing service to the Issuer on the following dates, the DRSUs shall vest on the earlier of: (i) the first anniversary of the Transaction Date; or (2) the day prior to the Issuer's next annual shareholder meeting. Notwithstanding the vesting, the issuance of the common stock will be deferred until the earlier of (i) three months after the Reported Person's resignation or removal from the Board of Directors or no longer providing service because of death or disability, (ii) a change in control (as defined in the DRSU agreement) or (iii) ten years from the Transaction Date.